A fresh shine on cystic fibrosis inhalation therapy: antimicrobial synergy of polymyxin B in combination with silver nanoparticles

- Jasim, Raad, Schneider, Elena K., Han, Meiling, Azad, Mohammad A. K., Hussein, Maytham, Nowell, Cameron, Baker, Mark A., Wang, Jiping, Li, Jian, Velkov, Tony

An "unlikely" pair: the antimicrobial synergy of polymyxin B in combination with the cystic fibrosis transmembrane conductance regulator drugs KALYDECO and ORKAMBI

- Schneider, Elena K., Azad, Mohammad A. K., Muller, Mark T., Li, Jian, Velkov, Tony, Han, Mei-Ling, Zhou, Qi (Tony), Wang, Jiping, Huang, Johnny X., Cooper, Matthew A., Doi, Yohei, Baker, Mark A., Bergen, Phillip J.

Drug-drug plasma protein binding interactions of ivacaftor

- Schneider, Elena K., Huang, Johnny X., Carbone, Vincenzo, Baker, Mark, Azad, Mohammad A. K., Cooper, Matthew A., Li, Jian, Velkov, Tony

Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae

- Velkov, Tony, Deris, Zakuan Z., Cooper, Matthew A., Nation, Roger L., Li, Jian, Huang, Johnny X., Azad, Mohammad A. K., Butler, Mark, Sivanesan, Sivashangarie, Kaminskas, Lisa M., Dong, Yao-Da, Boyd, Ben, Baker, Mark A.

Molecular basis for the increased polymyxin susceptibility of Klebsiella pneumoniae strains with under-acylated lipid A

- Velkov, Tony, Soon, Rachel L., Clements, Abigail, Strugnell, Richard A., Li, Jian, Chong, Pei L., Huang, Johnny X., Cooper, Matthew A., Azad, Mohammad A. K., Baker, Mark A., Thompson, Philip E., Roberts, Kade, Nation, Roger L.

Drug-binding energetics of human α-1-acid glycoprotein assessed by isothermal titration calorimetry and molecular docking simulations

- Huang, Johnny X., Cooper, Matthew A., Baker, Mark A., Azad, Mohammad A. K., Nation, Roger L., Li, Jian, Velkov, Tony

Molecular characterization of lipopolysaccharide binding to human α-1-acid glycoprotein

- Huang, Johnny X., Azad, Mohammad A. K., Yuriev, Elizabeth, Baker, Mark A., Nation, Roger L., Li, Jian, Cooper, Matthew A., Velkov, Tony